Abbott Labs
- ABT
- NYSE
- Consumer Products
- Latest 37.48
- Currency US$
- Change -0.24
- Percent Change -0.636 %
- Volume 7,067,651
- Thu May 23, 2013 4:04 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 37.49
- Previous Close 37.72
- High 37.86
- Low 37.30
- Bidx1 36.00
- Askx3 38.75
- 52-week High 05/22 38.77
- 52-week Low 06/05 28.45
- Beta 1.087
- Market Cap 58,869.09M
- EPS 4.46
- P/E 8.40
- Forward P/E 16.511
- PEG 1.56
- Annual Dividend 0.56
- Yield 1.494
News
- FDA warns on use of certain migraine drugs during pregnancy
- UPDATE 2-U.S. task force calls for routine HIV testing for all adults
- UPDATE 1-Task force calls for routine HIV testing for all adults
- Bristol-Myers standing out in the crowd
- UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug
- Abbott to Present at Deutsche Bank 38th Annual Health Care Conference
- Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
- Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
- Abbott to Present at UBS Global Healthcare Conference
- Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients
Financials & Calendars
- Sales $35,795,000,000
- Earnings $5,265,000,000
- Return on Equity 21.27%
- Cash Flow --
- Cash $4,373,120,000
- Current Ratio 1.84
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $42,686,610,000
- Liabilities $20,003,340,000
- Liabilities-to-Equity Ratio 0.88
Price Ratios
- Price to Sales 1.64
- Price to Book 2.60
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 17 | $0.42 | Jul 17 | $0.44 |
| Surprises | Jan 23 | 1.33% | n/a | n/a |
| Dividends | Apr 11 | $0.14 | n/a | n/a |
| Splits | Jan 2 | 1:.47847 | n/a | n/a |
12 months ended May 24, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Officers
- Miles D. White Chairman of the Board; Chief E
- Thomas C. Freyman Executive Vice President; Fina
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
100 ABBOTT PARK ROAD D-322 APABBOTT PARK, IL
Phone: 8479376100
Fax: (847)-9371511
Ideas & Discussion
Live Discussion of ABT on StockTwits